Go Pro
→ The dollar reset no one told you about (From Porter & Company) (Ad)tc pixel Free SUN Stock Alerts

Surgical Innovations Group (SUN) Competitors

Surgical Innovations Group logo
GBX 0.45 -0.05 (-10.00%)
As of 05:30 AM Eastern
Compare

SUN vs. BRY, MXC, HNR, NOG, and WRES

Should you buy Surgical Innovations Group stock or one of its competitors? MarketBeat compares Surgical Innovations Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgical Innovations Group include Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), Nostrum Oil & Gas (NOG), and W Resources (WRES). These companies are all part of the "petroleum and natural gas" industry.

How does Surgical Innovations Group compare to Brady?

Surgical Innovations Group (LON:SUN) and Brady (LON:BRY) are both small-cap petroleum and natural gas companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Brady£22.16M0.00N/A-£3.70N/A

2.8% of Surgical Innovations Group shares are held by institutional investors. 22.2% of Surgical Innovations Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Brady. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Brady. Surgical Innovations Group's average media sentiment score of 0.67 beat Brady's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
Brady Neutral

Brady has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Brady's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Brady N/A N/A N/A

Summary

Surgical Innovations Group beats Brady on 6 of the 10 factors compared between the two stocks.

How does Surgical Innovations Group compare to Argent BioPharma?

Argent BioPharma (LON:MXC) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Argent BioPharma. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Argent BioPharma. Surgical Innovations Group's average media sentiment score of 0.67 beat Argent BioPharma's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.

Company Overall Sentiment
Argent BioPharma Neutral
Surgical Innovations Group Positive

Argent BioPharma has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Argent BioPharma's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharmaN/A N/A -58.96%
Surgical Innovations Group -4.96%-6.04%-3.03%

Surgical Innovations Group has higher revenue and earnings than Argent BioPharma. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

1.2% of Argent BioPharma shares are held by institutional investors. Comparatively, 2.8% of Surgical Innovations Group shares are held by institutional investors. 8.2% of Argent BioPharma shares are held by company insiders. Comparatively, 22.2% of Surgical Innovations Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Argent BioPharma has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Surgical Innovations Group has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market.

Summary

Surgical Innovations Group beats Argent BioPharma on 8 of the 11 factors compared between the two stocks.

How does Surgical Innovations Group compare to Highlands Natural Resources?

Surgical Innovations Group (LON:SUN) and Highlands Natural Resources (LON:HNR) are both small-cap petroleum and natural gas companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Highlands Natural Resources. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Highlands Natural Resources. Surgical Innovations Group's average media sentiment score of 0.67 beat Highlands Natural Resources' score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
Highlands Natural Resources Neutral

Highlands Natural Resources has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Highlands Natural Resources' return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Highlands Natural Resources N/A N/A N/A

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A

2.8% of Surgical Innovations Group shares are held by institutional investors. 22.2% of Surgical Innovations Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Surgical Innovations Group beats Highlands Natural Resources on 6 of the 10 factors compared between the two stocks.

How does Surgical Innovations Group compare to Nostrum Oil & Gas?

Surgical Innovations Group (LON:SUN) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Surgical Innovations Group has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.751, meaning that its share price is 25% less volatile than the broader market.

Surgical Innovations Group has higher earnings, but lower revenue than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Nostrum Oil & Gas£120.77M0.04-£121.71M-£134.00N/A

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by insiders. Comparatively, 44.0% of Nostrum Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Nostrum Oil & Gas. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Nostrum Oil & Gas. Surgical Innovations Group's average media sentiment score of 0.67 beat Nostrum Oil & Gas' score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
Nostrum Oil & Gas Neutral

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Nostrum Oil & Gas -184.95%88.74%1.53%

Nostrum Oil & Gas has a consensus target price of GBX 4, indicating a potential upside of 24.80%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 14 factors compared between the two stocks.

How does Surgical Innovations Group compare to W Resources?

Surgical Innovations Group (LON:SUN) and W Resources (LON:WRES) are both small-cap petroleum and natural gas companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

In the previous week, Surgical Innovations Group had 1 more articles in the media than W Resources. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for W Resources. Surgical Innovations Group's average media sentiment score of 0.67 beat W Resources' score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
W Resources Neutral

Surgical Innovations Group has a net margin of -4.96% compared to W Resources' net margin of -174.96%. Surgical Innovations Group's return on equity of -6.04% beat W Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
W Resources -174.96%-33.02%-2.04%

Surgical Innovations Group has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market. Comparatively, W Resources has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Surgical Innovations Group has higher revenue and earnings than W Resources. Surgical Innovations Group is trading at a lower price-to-earnings ratio than W Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
W Resources£3.47M0.00-£6.06M-£6.10N/A

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 4.6% of W Resources shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Comparatively, 28.0% of W Resources shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Surgical Innovations Group beats W Resources on 6 of the 11 factors compared between the two stocks.

Get Surgical Innovations Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SUN vs. The Competition

Export
MetricSurgical Innovations GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£4.20M£2.10B£6.86B£2.78B
Dividend Yield2.63%2.66%2.68%6.12%
P/E Ratio-4.5015.2122.24368.21
Price / Sales0.36130.69524.2584,742.79
Price / Cash5.0315.9948.5927.87
Price / Book0.454.6510.807.52
Net IncomeN/A£144.75M£3.59B£5.89B
7 Day Performance-0.44%0.31%-2.24%-0.18%
1 Month Performance-2.39%1.50%3.12%-0.92%
1 Year Performance-37.50%0.10%26.30%61.94%

Surgical Innovations Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SUN
Surgical Innovations Group
N/AGBX 0.45
-10.0%		N/A-32.9%£4.20M£11.60MN/A80
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16
NOG
Nostrum Oil & Gas
1.2735 of 5 stars		GBX 3.20
-8.5%		GBX 4
+25.0%		+6.1%£5.28M£120.77MN/A30

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SUN) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
How much money does your next trade really require?
If a stock trades at $300, most investors assume they need $300 per share. Sean Allison says that assumption m...
Trade Thirsty | Sponsoredtc pixel
Get the golden rules of day trading for free
Roger Scott spent over three decades trading through the dot-com bust, the financial crisis, the COVID crash, ...
The TradingPub | Sponsoredtc pixel
60 years. Zero competitors.
One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...
Behind the Markets | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel